Physical Activity clinical trials

Explore recruiting physical activity clinical trials.

Recruiting physical activity studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Physical Activity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PAmidronate for Pain in Sternocostoclavicular hyperostosis: the PAPS-study, a double-blind randomized placebo-controlled trial (PAPS)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Prospective Real-World Evidence Study Evaluating the Effects of Voltaren use on Mobility and Quality of Life

Poland

Phase III and phase IV (Integrated) EU CTIS Study details

The role of meldonium and individualized physical activities in the treatment of patients with heart failure

Latvia

Therapeutic use (Phase IV) EU CTIS Study details

Impact of oxygen therapy in exertion in physical activity of patients with fibrotic intertitial lung disease with exertional hypoxemia (AFOX study)

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

The effect of Broncho-Vaxom on the COPD exacerbations in terms of lung function, lung mechanics, immune state, body composition, quality of life and physical activity.

Hungary

Therapeutic use (Phase IV) EU CTIS Study details

A Multicenter, Open-Label Phase IV Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes, in Participants Aged ≥13 and < 70 Years with Severe or Moderate Hemophilia a Without FVIII Inhibitors on Emicizumab Prophylaxis

Italy, Spain, Hungary, Germany

Therapeutic use (Phase IV) EU CTIS Study details

Physical Activity trials by city

Physical Activity in Toronto Physical Activity in Vancouver Physical Activity in Montreal Physical Activity in Calgary Physical Activity in Edmonton Physical Activity in Ottawa Physical Activity in Winnipeg Physical Activity in Quebec City Physical Activity in Hamilton Physical Activity in Kitchener Physical Activity in London Physical Activity in Halifax Physical Activity in New York Physical Activity in Los Angeles Physical Activity in Chicago Physical Activity in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease